ACRBP and neoplasm: Okumura et al.29have identified an HLA‐A24‐restricted ACRBP CD 8 T‐cell epitope, TES401‐409, which can be recognized by CD 8+ T cells and induced cytotoxicity against tumor cell line expressing ACRBP mRNA.